Quest Diagnostics (DGX) PT Raised to $104.50 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Quest Diagnostics (DGX) PT Raised to $115 at Canaccord Genuity Following Strong 1Q Report; 'Continues to Prove Skeptics Wrong... Q1 was a Blowout'
April 24, 2017 9:35 AM EDTCanaccord Genuity raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following the company's first quarter report.
Analyst Mark Massaro notes the company provided one of its best earnings reports in 4 years, delivering first quarter... More
Quest Diagnostics (DGX) PT Raised to $115 at UBS; 'Improved Growth Profile Continues to Build Confidence'
April 24, 2017 9:14 AM EDTUBS raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following a company update post first quarter results.
Analyst A.J. Rice notes management's strong execution of growth opportunities such as hospital deals that could... More
Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank
April 21, 2017 8:26 AM EDTDeutsche Bank raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $108.00) while maintaining a Buy rating.
... MoreQuest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
April 20, 2017 6:47 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.33, $0.15 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.87 billion.
"We delivered strong growth across the board in the first quarter with gains in revenues,... More
